NeoGenomics is trading 5.25% lower at $16.14 on October 22, 2026, amid broader market weakness, though the precise cause is not established. - No new company-specific announcement explaining the decline appeared in available search results; investor relations lists its latest releases on October 15 and October 14, with third-quarter results scheduled for October 28. - Nasdaq is down 2.45% and the S&P 500 is down 1.34%, while healthcare is up 1.35%; volume data was unavailable.